valine has been researched along with Delayed Hypersensitivity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farmer, L; Hogan, JK; Hoock, TC; Mahajan, S; Oh, L; Salituro, FG; Shlyakhter, D | 1 |
| Baumal, R; Bloom, B; Scharff, MD | 1 |
2 other study(ies) available for valine and Delayed Hypersensitivity
| Article | Year |
|---|---|
VX-509 (decernotinib) is a potent and selective janus kinase 3 inhibitor that attenuates inflammation in animal models of autoimmune disease.
Topics: Animals; Arthritis, Experimental; Autoimmune Diseases; Disease Models, Animal; Edema; Female; Heterocyclic Compounds, 2-Ring; Humans; Hypersensitivity, Delayed; Inflammation; Janus Kinase 1; Janus Kinase 2; Janus Kinase 3; Male; Mice; Protein Kinase Inhibitors; Rats; Valine | 2015 |
Induction of long term lymphocyte lines from delayed hypersensitive human donors using specific antigen plus Epstein-Barr virus.
Topics: Antibody-Producing Cells; Antigens; Cell Line; Electrophoresis, Disc; Herpesviridae; Herpesvirus 4, Human; Humans; Hypersensitivity, Delayed; Immunoglobulins; In Vitro Techniques; Leucine; Lymphocytes; Streptodornase and Streptokinase; Threonine; Tuberculin; Valine | 1971 |